Efficacy and safety of larotrectinib in neurotrophic tyrosine receptor kinase fusion-positive solid tumors: A multicenter retrospective cohort study in Korea

被引：0

作者：

Lee, S. ^{[1
]}

Yoon, S. ^{[2
]}

Choi, W. ^{[3
]}

Jung, H. A. ^{[4
]}

Bae, S. B. ^{[5
]}

Kim, C. G. ^{[6
]}

Kim, H. R. ^{[7
]}

Lee, K-w. ^{[8
,14
]}

Kang, E. J. ^{[9
]}

Shin, K. ^{[10
,11
]}

Lim, D-j. ^{[12
]}

Kim, . s.

Park, S. ^{[13
]}

Lee, K-e.

Lee, Y. ^{[15
]}

Kim, H. S. ^{[16
]}

Kim, T. J. ^{[17
]}

Kim, M. J. ^{[18
]}

Kang, J. H. ^{[19
]}

机构：

[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Med Oncol,Dept Internal Med, Seoul, South Korea

[2] Univ Ulsan, Asan Med Ctr, Oncol Dept, Seoul, South Korea

[3] Ctr Clin Trials, Natl Canc Ctr, NCC, Goyang, South Korea

[4] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr SMC, Div Hematol Oncol,Sch Med, Seoul, South Korea

[5] Soonchunhyang Univ Hosp, Dept Internal Med, Div Hematooncol, Cheonan, South Korea

[6] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr, Seoul, South Korea

[7] Yonsei Univ, Med Oncol Dept, Yonsei Canc Ctr, Seoul, South Korea

[8] Seoul Natl Univ, Internal Med Dept, Bundang Hosp, Seongnam, South Korea

[9] Korea Univ, Guro Hosp, Dept Internal Med, Div Med Oncol, Seoul, South Korea

[10] Catholic Univ Korea, Internal Med Dept, Seoul, South Korea

[11] Seoul St Marys Hosp, Catholic Med Ctr, Seoul, South Korea

[12] Catholic Univ Korea, Seoul St Marys Hosp, Endocrinol, Seoul, South Korea

[13] Samsung Med Ctr SMC, Hematol & Med Oncol, Seoul, South Korea

[14] Ewha Womans Univ, Mokdong Hosp, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea

[15] Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea

[16] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea

[17] Catholic Univ Korea, Dept Hosp Pathol, Yeouido St Marys Hosp, Coll Med, Seoul, South Korea

[18] Catholic Univ Korea, Dept Hosp Pathol, Seoul St Marys Hosp, Coll Med, Seoul, South Korea

[19] Catholic Univ Korea, Seoul St Marys Hosp, Catholic Med Ctr, Med Oncol Dept, Seoul, South Korea

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.10.517

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

492P

引用

页数：2

共 50 条

[1] Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial
Yilmaz, Feride
Yasar, Serkan
Mandel, Nil Molinas
Kacan, Turgut
Ozdemir, Melek
Dogu, Gamze Gokoz
Sengul, Nilay
Meydan, Nezih
Basal, Fatma Bugdayci
Tolunay, Pinar Kubilay
Hamamci, Melda Berber
Dincer, Oguz Salih
Bahceci, Aykut
Ozer, Leyla
Ajredini, Mirac
Kirca, Onder
Yersal, Ozlem
Can, Orcun
Gunaldi, Meral
Demir, Gokhan
Yalcin, Suayib
TARGETED ONCOLOGY, 2024, 19 (06) : 957 - 964
[2] Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers
Drilon, Alexander
Tan, Daniel S. W.
Lassen, Ulrik N.
Leyvraz, Serge
Liu, Yongmei
Patel, Jyoti D.
Rosen, Lee
Solomon, Benjamin
Norenberg, Ricarda
Dima, Laura
Brega, Nicoletta
Shen, Lin
Moreno, Victor
Kummar, Shivaani
Lin, Jessica J.
JCO PRECISION ONCOLOGY, 2022, 6
[3] Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors
Rosen, Ezra Y.
Schram, Alison M.
Young, Robert J.
Schreyer, Mark W.
Hechtman, Jaclyn F.
Shu, Catherine A.
Ku, Nora C.
Hyman, David M.
Drilon, Alexander
JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 5
[4] Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase (TRK) Fusion-Positive Lung Cancer
Drilon, A.
Lin, J.
Lassen, U.
Leyvraz, S.
Liu, Y.
Patel, J.
Rosen, L.
Solomon, B.
Norenberg, R.
Dima, L.
Brega, N.
Shen, L.
Moreno, V.
Kummar, S.
Tan, D.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1125 - S1126
[5] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset
Boni, V.
Drilon, A.
Deeken, J.
Garralda, E.
Chung, H.
Kinoshita, I.
Oh, D.
Patel, J.
Xu, R.
Norenberg, R.
Brega, N.
Dima, L.
Hong, D.
Berlin, J.
ANNALS OF ONCOLOGY, 2021, 32 : S214 - S215
[6] Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
Doz, Francois
van Tilburg, Cornelis M.
Geoerger, Birgit
Hojgaard, Martin
Ora, Ingrid
Boni, Valentina
Capra, Michael
Chisholm, Julia
Chung, Hyun Cheol
DuBois, Steven G.
Gallego-Melcon, Soledad
Gerber, Nicolas U.
Goto, Hiroaki
Grilley-Olson, Juneko E.
Hansford, Jordan R.
Hong, David S.
Italiano, Antoine
Kang, Hyoung Jin
Nysom, Karsten
Thorwarth, Anne
Stefanowicz, Joanna
Tahara, Makoto
Ziegler, David S.
Gavrilovic, Igor T.
Norenberg, Ricarda
Dima, Laura
De la Cuesta, Esther
Laetsch, Theodore W.
Drilon, Alexander
Perreault, Sebastien
NEURO-ONCOLOGY, 2022, 24 (06) : 997 - 1007
[7] EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
Perreault, Sebastien
Doz, Francois
Geoerger, Birgit
Nysom, Karsten
Ora, Ingrid
Boni, Valentina
Chisholm, Julia
DuBois, Steven G.
Gerber, Nicolas U.
Goto, Hiroaki
Grilley-Olson, Juneko E.
Hansford, Jordan R.
Kang, Hyoung Jin
Capra, Michael
Schulte, Johannes H.
Stefanowicz, Joanna
Tahara, Makoto
Ziegler, David S.
Norenberg, Ricarda
Dima, Laura
De La Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2021, 23 : 42 - 42
[8] Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans
Zhou, Katherine I.
Vashistha, Vishal
Guo, Aixia
Ahmed, Sara
Kelley, Michael J.
JCO PRECISION ONCOLOGY, 2023, 7
[9] EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE CANCER: AN EXPANDED DATASET
Koga, Yuhki
PEDIATRIC BLOOD & CANCER, 2022, 69
[10] Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system tumors.
Perreault, Sebastien
van Tilburg, Cornelis Martinus
Geoerger, Birgit
Nysom, Karsten
Ora, Ingrid
Gavrilovic, Igor T.
Norenberg, Ricarda
Dima, Laura
De La Cuesta, Esther A.
Drilon, Alexander E.
Doz, Francois P.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →